MEDLINE ($MDLN) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of -$0.01 per share, missing estimates of $0.25 by $0.26. The company also reported revenue of $7,787,000,000, beating estimates of $7,698,190,593 by $88,809,407.
You can see Quiver Quantitative's $MDLN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MEDLINE Insider Trading Activity
MEDLINE insiders have traded $MDLN stock on the open market 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $MDLN stock by insiders over the last 6 months:
- PRIVATE LTD GIC has made 1 purchase buying 12,586,206 shares for an estimated $364,999,974 and 1 sale selling 10,204,351 shares for an estimated $289,480,090.
- GROUP INC. CARLYLE sold 19,136,333 shares for an estimated $554,953,657
- GROUP VII S1, L.L.C. TC sold 19,136,333 shares for an estimated $554,953,657
- MOZART COINVESTMENT HOLDINGS, L.P. CARLYLE sold 19,136,333 shares for an estimated $554,953,657
- AGGREGATOR II LP MOZART sold 13,462,600 shares for an estimated $381,911,075
- & FRIEDMAN CAPITAL PARTNERS X (PARALLEL), L.P. HELLMAN has made 0 purchases and 3 sales selling 6,088,371 shares for an estimated $172,716,735.
- ANDREW J. MILLS purchased 2,586,206 shares for an estimated $74,999,974
- CHARLES N. MILLS has made 2 purchases buying 2,579,310 shares for an estimated $74,799,990 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MEDLINE Hedge Fund Activity
We have seen 197 institutional investors add shares of MEDLINE stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CARLYLE GROUP INC. added 215,303,036 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,042,727,512
- H&F CORPORATE INVESTORS X, LTD. added 99,514,069 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,179,590,898
- FMR LLC added 26,354,214 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,106,876,988
- VANGUARD GROUP INC added 18,887,568 shares (+inf%) to their portfolio in Q4 2025, for an estimated $793,277,856
- MORGAN STANLEY added 15,162,060 shares (+inf%) to their portfolio in Q4 2025, for an estimated $636,806,520
- CAPITAL RESEARCH GLOBAL INVESTORS added 14,784,203 shares (+inf%) to their portfolio in Q4 2025, for an estimated $620,936,526
- LONE PINE CAPITAL LLC added 11,716,697 shares (+inf%) to their portfolio in Q4 2025, for an estimated $492,101,274
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MEDLINE Analyst Ratings
Wall Street analysts have issued reports on $MDLN in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/12/2026
- Barclays issued a "Overweight" rating on 01/12/2026
- RBC Capital issued a "Outperform" rating on 01/12/2026
- Citigroup issued a "Buy" rating on 01/12/2026
- Bernstein issued a "Outperform" rating on 01/12/2026
- Wolfe Research issued a "Outperform" rating on 01/12/2026
To track analyst ratings and price targets for MEDLINE, check out Quiver Quantitative's $MDLN forecast page.
MEDLINE Price Targets
Multiple analysts have issued price targets for $MDLN recently. We have seen 23 analysts offer price targets for $MDLN in the last 6 months, with a median target of $48.0.
Here are some recent targets:
- Ivan Feinseth from Tigress Financial set a target price of $55.0 on 02/05/2026
- Eric Coldwell from Baird set a target price of $48.0 on 01/12/2026
- Ed Ridley-Day from Rothschild & Co set a target price of $42.0 on 01/12/2026
- Michael Cherny from Leerink Partners set a target price of $48.0 on 01/12/2026
- Patrick Wood from Morgan Stanley set a target price of $48.0 on 01/12/2026
- Steven Valiquette from Mizuho set a target price of $48.0 on 01/12/2026
- Jason Bednar from Piper Sandler set a target price of $50.0 on 01/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
